These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13214391)

  • 1. Acute hallucinosis secondary to pagitane hydrochloride administration.
    PIERIK MG
    N Engl J Med; 1954 Dec; 251(26):1058. PubMed ID: 13214391
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of pagitane hydrochloride in parkinsonism.
    DOW RS; SMITH GN
    Neurology; 1954 Jan; 4(1):33-9. PubMed ID: 13133049
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of parkinsonism with pagitane hydrochloride; results in 142 patients.
    ZIER A; DOSHAY LJ
    Neurology; 1954 Sep; 4(9):682-9. PubMed ID: 13214268
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-Parkinson drugs and their relationship to glaucoma.
    EDWARDS CE; O'DOHERTY DS
    Bull Georgetown Univ Med Cent; 1958 Sep; 12(1):15-6. PubMed ID: 13573001
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethopropazine (parsidol) hydrochloride in treatment of paralysis agitans; posology, method of administration, and effects.
    DOSHAY LJ; CONSTABLE K; AGATE FJ
    J Am Med Assoc; 1956 Feb; 160(5):348-51. PubMed ID: 13278201
    [No Abstract]   [Full Text] [Related]  

  • 6. [The benztropine methanesulfonate anti Parkinsonian agent].
    POCH GF
    Rev Asoc Med Argent; 1958 Sep; 72(9):357-60. PubMed ID: 13614757
    [No Abstract]   [Full Text] [Related]  

  • 7. [Akineton psychoses].
    STEINBRECHER W
    Dtsch Med Wochenschr; 1958 Aug; 83(33):1399-400. PubMed ID: 13573928
    [No Abstract]   [Full Text] [Related]  

  • 8. NEW AND nonofficial remedies: cycrimine hydrochloride.
    J Am Med Assoc; 1955 Feb; 157(6):510-1. PubMed ID: 13221464
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lyseen (HH 212), a new substance for the treatment of extrapyramidal disorders and of muscle spasms of central and peripheral origin].
    SCHULZ HP
    Munch Med Wochenschr; 1961 May; 103():1066-8. PubMed ID: 13748916
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences in the treatment of parkinsonism & other extrapyramidal disorders].
    KONIG JK
    Medizinische; 1959 Feb; 4(9):388-9. PubMed ID: 13643481
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephrotoxicity associated with zoxazolamine administration.
    STREITZ JM
    N Engl J Med; 1959 Jun; 260(25):1278-9. PubMed ID: 13666952
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative measurement of therapy in paralysis agitans.
    AGATE FJ; DOSHAY LJ; CURTIS FK
    J Am Med Assoc; 1956 Feb; 160(5):352-4. PubMed ID: 13278202
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of 267C (1-(1-piperidyl)-6-methyl-3-phenyl-3-heptanol hydrochloride) in Parkinson's disease.
    GIANVITO L; JACKSON I; MCGAVACK TH
    J Am Geriatr Soc; 1956 Aug; 4(8):793-6. PubMed ID: 13357272
    [No Abstract]   [Full Text] [Related]  

  • 14. Antispasmodic compound 08958 in treatment of paralysis agitans.
    MAGEE KR; DEJONG RN
    J Am Med Assoc; 1953 Oct; 153(8):715-8. PubMed ID: 13096281
    [No Abstract]   [Full Text] [Related]  

  • 15. Nephropathy associated with the oral administration of zoxazolamine (flexin); report of a case.
    COHEN T
    N Engl J Med; 1957 Jun; 256(25):1193-4. PubMed ID: 13452021
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical observations on the relation of muscular rigidity and tremor in idiopathic paralysis agitans.
    PARK HW; HAJEK-NICHOLS N
    South Med J; 1959 Oct; 52():1246-8. PubMed ID: 14430469
    [No Abstract]   [Full Text] [Related]  

  • 17. [New methods of medicinal treatment of extrapyramidal disorders, with special reference to parkinsonism & postencephalitic parkinsonism].
    RUTHER W; THEISS W
    Med Klin; 1958 Aug; 53(35):1495-7. PubMed ID: 13589544
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary study of a new anti-parkinson agent.
    DOSHAY LJ; CONSTABLE K; FROMER S
    Neurology; 1952; 2(3):233-43. PubMed ID: 14929300
    [No Abstract]   [Full Text] [Related]  

  • 19. Five-year study of benztropine (cogentin) methanesulfonate; outcome in three hundred two cases of paralysis agitans.
    DOSHAY LJ
    J Am Med Assoc; 1956 Nov; 162(11):1031-4. PubMed ID: 13366700
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aturban in parkinsonism].
    PAKKENBERG H
    Ugeskr Laeger; 1960 Jan; 122():45-6. PubMed ID: 14429854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.